Group Training and Quality of Life and Reduction of Pain in Rheumatoid Arthritis Patients




It is documented that some patient education interventions, preferably with a behavioral component included, may improve pain, disability and moods Purpose of the study: the purpose of this study was to improve the quality of life and reduce pain in rheumatoid arthritis patients.


Patients were allocated to a patient training intervention group and patient without training intervention group. Both groups received routine treatments while the patient training intervention group, in addition to the routine treatments received training booklets and participated in the training workshop. All the extracted data from the written questionnaire were collected and analyzed using SPSS software.

Full Title of Study: “The Effect of Group Training on the Quality of Life and Reduction of Pain in Rheumatoid Arthritis Patients”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Supportive Care
    • Masking: None (Open Label)
  • Study Primary Completion Date: January 2009

Detailed Description


The improvement in the signs of recovery for physical and mood symptoms in the patient training intervention group were seen (p < 0.05). The score of quality of life had significantly improved in the two groups (Mean difference was 9.31±3.03 and P<0.003). This improvement was significantly higher in the patient training intervention group (P=0.008). After adjustment for education level, the score of quality of life in patient training intervention group had a higher improvement, but the difference between the two groups was not significant (P = 0.1).


This study showed the important role of training and the patients' educational level on better treatments. The appropriate training in the patient could create a change in the treatment process and has a better effect on quality of life.


  • Behavioral: training leaflet and oral training
    • The intervention consisted of training leaflet and oral training. All of the patients were new cases and were divided into 2 groups. All patients were treated with routine medication, no addition medication for two groups were done, the case group attended the workshops and were trained In addition to medical therapy, continuing education and training workshop. The result of the effect of workshop was also filling out a questionnaire before and after training. Finally, two groups with statistical analysis were compared.

Arms, Groups and Cohorts

  • Experimental: patient training and patient without training
    • Experimental group 1: patient education intervention group (PIGE) Experimental group 2: patient without intervention group (PWIG)
  • No Intervention: control without education
    • this group did not receive an education

Clinical Trial Outcome Measures

Primary Measures

  • The score of quality of life had significantly improved in the two groups (using questionnaire)
    • Time Frame: one year

Secondary Measures

  • In the present study a greater percentage of patients reported less pain after intervention (using questionnaire)
    • Time Frame: one year

Participating in This Clinical Trial

Inclusion Criteria

  • The only inclusion criterion was that the patient had RA as the main disease (with the same duration and severity of disease).

Exclusion Criteria

  • Patients were excluded if they had another disease.

Gender Eligibility: All

Minimum Age: 34 Years

Maximum Age: 60 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Tehran University of Medical Sciences
  • Provider of Information About this Clinical Study
    • Principal Investigator: Zahra Khazaeipour, Principal Investigator – Tehran University of Medical Sciences

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.